Report overview
Total Artificial Heart (TAH) is a prosthetic device that is implanted into the body to replace the biological heart. A few proprietary artificial heart devices have been developed including the Syncardia TAH, AbioCor (Abiomed, Danvers, Massachusetts, USA), and CARMAT (Carmat, Velizy, France). The history of these devices and their clinical use has recently been reviewed. Among the devices listed, the Syncardia (TAH) is the only device currently in use. The CARMAT is currently undergoing feasibility studies, however, data has been limited to a handful of patients thus far. There is also no data on the use of the AbioCor or CARMAT in patients with CHD.
This report aims to provide a comprehensive presentation of the global market for Total Artificial Heart, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Total Artificial Heart. This report contains market size and forecasts of Total Artificial Heart in global, including the following market information:
Global Total Artificial Heart Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Total Artificial Heart Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Total Artificial Heart companies in 2022 (%)
The global Total Artificial Heart market was valued at US$ 40 million in 2022 and is projected to reach US$ 150.3 million by 2029, at a CAGR of 20.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Total Artificial Heart key players include only SynCardia, with a share about 100%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 40 percent. In terms of product, SynCardia is the largest segment, with a share about 100%. And in terms of application, the largest application is Ischemic Cardiomyopathy, followed by Dilated Cardiomyopathy, etc.
We surveyed the Total Artificial Heart manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Total Artificial Heart Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Total Artificial Heart Market Segment Percentages, by Type, 2022 (%)
SynCardia
Others
Global Total Artificial Heart Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Total Artificial Heart Market Segment Percentages, by Application, 2022 (%)
Dilated Cardiomyopathy
Ischemic Cardiomyopathy
Others
Global Total Artificial Heart Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Total Artificial Heart Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Total Artificial Heart revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Total Artificial Heart revenues share in global market, 2022 (%)
Key companies Total Artificial Heart sales in global market, 2018-2023 (Estimated), (Units)
Key companies Total Artificial Heart sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BiVACOR
SynCardia
Jarvik Heart
CARMAT
AbioMed
Outline of Major Chapters:
Chapter 1: Introduces the definition of Total Artificial Heart, market overview.
Chapter 2: Global Total Artificial Heart market size in revenue and volume.
Chapter 3: Detailed analysis of Total Artificial Heart manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Total Artificial Heart in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Total Artificial Heart capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
